National Health Investors (NYSE:NHI) Stock Price Expected to Rise, Truist Financial Analyst Says

National Health Investors (NYSE:NHI - Free Report) had its target price lifted by Truist Financial from $70.00 to $76.00 in a research report released on Wednesday morning,Benzinga reports. They currently have a hold rating on the real estate investment trust's stock.

Separately, Wedbush reissued an "outperform" rating and set a $88.00 target price on shares of National Health Investors in a research note on Monday, March 17th. Three analysts have rated the stock with a hold rating and two have issued a buy rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Hold" and an average price target of $85.50.

National Health Investors Trading Down 1.7 %

Shares of NYSE NHI traded down $1.28 during mid-day trading on Wednesday, hitting $73.47. The stock had a trading volume of 712,093 shares, compared to its average volume of 203,686. The business has a 50 day moving average price of $70.37 and a two-hundred day moving average price of $74.53. National Health Investors has a 1 year low of $57.80 and a 1 year high of $86.13. The company has a debt-to-equity ratio of 0.92, a quick ratio of 10.29 and a current ratio of 10.29. The firm has a market cap of $3.36 billion, a P/E ratio of 25.25, a price-to-earnings-growth ratio of 4.42 and a beta of 1.08.

Remove Ads

National Health Investors (NYSE:NHI - Get Free Report) last issued its quarterly earnings data on Tuesday, February 25th. The real estate investment trust reported $1.13 EPS for the quarter, beating the consensus estimate of $1.10 by $0.03. The firm had revenue of $85.75 million during the quarter, compared to the consensus estimate of $81.13 million. National Health Investors had a net margin of 38.53% and a return on equity of 10.11%. On average, equities analysts anticipate that National Health Investors will post 4.41 EPS for the current fiscal year.

National Health Investors Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 2nd. Shareholders of record on Monday, March 31st will be given a dividend of $0.90 per share. The ex-dividend date is Monday, March 31st. This represents a $3.60 annualized dividend and a yield of 4.90%. National Health Investors's payout ratio is 115.38%.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in NHI. Norges Bank bought a new position in National Health Investors in the fourth quarter worth $42,322,000. Millennium Management LLC boosted its stake in National Health Investors by 1,967.0% during the fourth quarter. Millennium Management LLC now owns 488,353 shares of the real estate investment trust's stock worth $33,843,000 after acquiring an additional 464,727 shares in the last quarter. Balyasny Asset Management L.P. purchased a new stake in National Health Investors in the fourth quarter worth about $23,917,000. Marshall Wace LLP increased its stake in shares of National Health Investors by 161.6% during the fourth quarter. Marshall Wace LLP now owns 551,585 shares of the real estate investment trust's stock valued at $38,225,000 after purchasing an additional 340,712 shares in the last quarter. Finally, Zimmer Partners LP bought a new position in shares of National Health Investors during the third quarter valued at approximately $25,218,000. Hedge funds and other institutional investors own 62.51% of the company's stock.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.